• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSS2400015 利妥昔单抗注射液 rituximab Injection Biological Products(3.3) New Drug Application 2024-01-27 Shandong New Time Pharmaceutical Co Ltd view
JYSB2300192 利妥昔单抗注射液 rituximab Injection Biological Products Supplementary Application 2023-11-07 view
JYSB2300191 利妥昔单抗注射液 rituximab Injection Biological Products Supplementary Application 2023-11-07 view
JYSB2300189 利妥昔单抗注射液 rituximab Injection Biological Products Supplementary Application 2023-11-07 view
JYSB2300190 利妥昔单抗注射液 rituximab Injection Biological Products Supplementary Application 2023-11-07 view
CYSB2300121 利妥昔单抗注射液 rituximab Injection Biological Products Supplementary Application 2023-06-27 Shanghai Henlius Biopharmaceutical Co Ltd view
CYSB2300120 利妥昔单抗注射液 rituximab Injection Biological Products Supplementary Application 2023-06-27 Shanghai Henlius Biopharmaceutical Co Ltd view
JYSB2300020 利妥昔单抗注射液 rituximab Injection Biological Products Supplementary Application 2023-02-07 view
JYSB2300019 利妥昔单抗注射液 rituximab Injection Biological Products Supplementary Application 2023-02-07 view
JYSB2300018 利妥昔单抗注射液 rituximab Injection Biological Products Supplementary Application 2023-02-07 view
JYSB2300017 利妥昔单抗注射液 rituximab Injection Biological Products Supplementary Application 2023-02-07 view
JXSS2300012 利妥昔单抗注射液(皮下注射) rituximab Injection Biological Products(3.1) Import Drug Application 2023-01-18 view
CXSS2200092 利妥昔单抗注射液 rituximab Injection Biological Products(3.3) New Drug Application 2022-12-13 Shanghai Institute of Biological Products Co Ltd view
CXSS2200086 利妥昔单抗注射液 rituximab Injection Biological Products(3.3) New Drug Application 2022-10-24 Shenghe (China) Biopharmaceutical Co Ltd view
CYSB2200098 利妥昔单抗注射液 rituximab Injection Biological Products Supplementary Application 2022-03-28 Shanghai Henlius Biopharmaceutical Co Ltd view
CXSS2200002 利妥昔单抗注射液 rituximab Injection Biological Products(3.3) New Drug Application 2022-01-11 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view
JYSB2101046 利妥昔单抗注射液 rituximab Injection Biological Products Supplementary Application 2021-06-04 view
JYSB2101048 利妥昔单抗注射液 rituximab Injection Biological Products Supplementary Application 2021-06-04 view
JYSB2101045 利妥昔单抗注射液 rituximab Injection Biological Products Supplementary Application 2021-06-04 view
JYSB2101047 利妥昔单抗注射液 rituximab Injection Biological Products Supplementary Application 2021-06-04 view